KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Hologic (HOLX) Current Deferred Revenue (2016 - 2025)

Hologic (HOLX) has disclosed Current Deferred Revenue for 17 consecutive years, with $170.9 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 8.85% to $170.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $170.9 million through Dec 2025, down 8.85% year-over-year, with the annual reading at $199.7 million for FY2025, 6.2% down from the prior year.
  • Current Deferred Revenue hit $170.9 million in Q4 2025 for Hologic, down from $199.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $232.9 million in Q3 2023 to a low of $170.9 million in Q4 2025.
  • Historically, Current Deferred Revenue has averaged $203.1 million across 5 years, with a median of $199.6 million in 2022.
  • Biggest five-year swings in Current Deferred Revenue: rose 21.7% in 2021 and later fell 9.76% in 2024.
  • Year by year, Current Deferred Revenue stood at $192.1 million in 2021, then fell by 0.26% to $191.6 million in 2022, then dropped by 0.52% to $190.6 million in 2023, then decreased by 1.63% to $187.5 million in 2024, then decreased by 8.85% to $170.9 million in 2025.
  • Business Quant data shows Current Deferred Revenue for HOLX at $170.9 million in Q4 2025, $199.7 million in Q3 2025, and $212.7 million in Q2 2025.